ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[CSF3, NCF1, PDGFA, CCL5, PDGFD, PDGFC, FYN, PDGFRB, PDGFRA, TGFB2, F2R, IL18, IGF1, SIRT1, PTK2, DCN, FGR, SELP, GH1, NEDD4, KIT, CD28, HCLS1, F2RL1, PTPN6, TEK]
GO:0021955;central nervous system neuron axonogenesis;9.0;0.7043150770688792;0.7483981637147287;8.801845679307654;65.99544162831262;6.375876246018314;0.0022088080392582156;0.722303232910233;[DCC, ADARB1, PTK2, NR4A2, CDH11, EPHB2, EPHB1]
GO:0022408;negative regulation of cell-cell adhesion;6.0;0.5806842727486619;0.6134624489644754;7.765305819281922;52.92767189200162;4.7081694254602375;0.0017714415464131104;0.5638963159604501;[, CD86, IL1RN, CD80, IFNA2, IHH, PTPN22, SPINT2, LRRC32, LGALS3, CDH1, TNR, CTLA4, JAK3, HAVCR2, IL10, LAG3, ANXA1, DUSP3, ARG1, CD300A, PRKCD, PAWR, PDCD1LG2, HLA-G, CEACAM1, XCL1, PDE5A, MAD1L1, CD274, CEBPB, ALOX12, EPB41L5, GPNMB, EPCAM, HLX, TBX21, TIGIT, PAG1, CD74, TGFB1, JAG1, CCL21, LILRB1, LILRB2, KLF4, PTK2, BMP2, CXCL12, BCL6, IL2RA, CD9, SNAI2, PTPN6, FCGR2B, NFKBID]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[, NUP107, TFRC, AKT1, WLS, ZFYVE16, GATA3, LYN, ABCA1, COL1A1, SRP9, MMP12, CENPF, SNX17, GOPC, NCF1, CSE1L, AP2M1, ADCYAP1, ACAP1, SLC27A2, LIN7A, EVI5, ARRB1, ARRB2, TNFSF13B, ITGB6, ARL4C, LCP2, LRP1, LRP2, SEC63, GOLPH3L, HNF1B, ACTN4, KIF20A, MSR1, EGR2, POLA2, TF, CD24, CD3G, PCSK5, AKAP12, CCR7, CD36, SYK, NAPA, HSD17B4, STX11, CD74, NEDD4, FKBP1B, RAMP1, SCARB2, ZFAND6, CARD11, ECT2, NUP155, NASP, PLEK, NUP62, YWHAH, NUP133, TBC1D8, TBC1D9, CHI3L1, NUP54, MX2, NUP35, RAN, PHB2, AP1S2, HOMER3, CUBN, PRKCB, NUP85, S100A12, NUP88, EHD3, DENND1B, ANXA1, EXOC1, CCL19, NR1H4, TNF, CLU, LAMP2, TAP1, RAB32, RAB31, CALCRL, SLC15A3, DAB2, BCL6, BCL3, CCDC22, PLEKHF2, TLK1, NLGN1, UNC93B1, VPS4B, NLRC4, NOD2, RAB21, PML, VPS41, IL1RN, IFIT1, ARFIP1, STXBP2, AHCTF1, TRAM2, XPO1, TMED6, STRADB, ZDHHC17, RAB33B, TLR6, TLR4, TLR2, RANBP2, RANBP1, LILRB1, RANBP6, CD40LG, F2RL1, NUPL2, STEAP3, GOLT1B, TSC2, ATP1B1, HGS, COPB2, SUCNR1, LTBP2, NLRP3, TGFB1, LRP1B, NFKBIA, TBCK, KIF18A, DNM2, IFNG, EHHADH, HSPD1]
GO:0007097;nuclear migration;5.0;0.7140352122741334;0.6472586179979869;8.712233520617966;66.0178211805495;6.781341354126479;0.002209557062731295;0.6370391240755715;[HHEX, CEP120, MYH10, PTK2]
GO:0051491;positive regulation of filopodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;6.409777797693995;0.006704083591926775;0.7240369598395108;[NRP1, NLGN1, CCL21, FMR1, ARAP1, DPYSL3, CCR7]
GO:0097490;sympathetic neuron projection extension;5.0;1.0;0.7902410118609202;9.628524252492122;51.99108915072818;8.390779266560578;0.0017400949649324319;0.7193458537639684;[NRP1, NRP2]
GO:0090050;positive regulation of cell migration involved in sprouting angiogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;645.2358217485536;6.7325511899570465;0.021595462279385098;0.7767319332797141;[NRP1, ANXA1, PLK2, HMOX1, PTGS2, PIK3C2A]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, ADM, BRCA1, PIK3C2A, ETS1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, CCR3, IL10, PPP1R16B, GHSR, ANXA1, ANXA3, PRKCB, GAB1, CYBB, SIRT1, F3, GREM1, IL1A, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, C3, RRAS, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0007413;axonal fasciculation;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;31.514364772604104;6.7325511899570465;0.0010547574278521217;0.6952223462072524;[NRP1, CNR1, NCAM2, EPHB2, EPHA3]
GO:0010812;negative regulation of cell-substrate adhesion;6.0;0.7980440201809971;0.722142322680643;9.117698628726131;52.01138116012746;5.769740442447999;0.001740774120225403;0.618185107137305;[SERPINE1, TACSTD2, FBLN1, ARHGAP6, THBS1, LGALS1, HOXA7, MEN1, POSTN, JAG1, ACTN4, COL1A1, BCL6, DLC1]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, GATA1, JUN, JAG1, JUP, NR2F2, COL1A1, HOXC10, DLGAP5, RIPK2, FOS, SIRT1, MMP12, PLSCR1, CKS2, STAT4, SPP1, STAT1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, RUVBL2, ADCYAP1, BLM, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CXCL10, CIITA, FHL2, ARRB1, FOXM1, HHEX, PPP1R12A, PEG3, UHRF1, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, POU2AF1, CCNH, CCNC, IKZF1, TNFSF11, HNF1B, SFRP2, EGR1, EGR2, EGR3, IGF1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3D, HNF4A, CD38, IL10, IL18, RGMA, IL1A, IL1B, YAP1, SATB2, RELB, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, EOMES, CCNE1, VDR, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL2, MYBL1, YWHAH, MYOCD, DDX58, ETV1, CCNA2, GREM1, PSRC1, ELF3, IRF7, IRF8, CREB5, TAF9, RNF6, TBX21, EGF, MAPK14, CD4, TNIP3, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, PRKDC, NUP85, RAD21, PRDM16, NKX2-3, FZD1, NFE2, FZD2, FZD5, FZD8, FOSL2, FOSL1, TGFB1I1, PAX5, PAX2, ZEB1, TAL1, RARA, HCLS1, PLCB1, ENG, NR1I2, EPCAM, NR1H2, NR1H4, GTF2H1, POU4F1, FOSB, PF4, CSF3, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, DAB2, COPS5, MAFB, MAFF, BCL3, CDK2, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, KLF4, PML, KLF1, KLF6, KLF5, GFI1, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR4, TLR2, SP100, APBB1, CDX2, CDX1, LILRB1, GRHL2, CAMK4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, CKS1B, KLF13, CKAP2, DCN, DNM2, LEF1, DLL1, LUM, MEIS2, MEIS1, RBMX]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[IHH, EDNRA, PDGFRA, TPM1, MSH2, TWIST1, GATA3, GATA1, EPB41L5, CCNB2, CCNB1, PLCG1, MYH10, STIL, EIF2S2, FOSL1, BMP2, MAFF, BCL2L1, PTPRR, TMEM100, HHEX, EDN1, DUSP3, RXRA, TIE1]
GO:0050714;positive regulation of protein secretion;8.0;0.6467165523344657;0.6983582761672329;8.730582659286164;381.48337166918856;4.304802954008995;0.01276790513702299;0.5951478232618299;[FCN1, TNF, PYCARD, CLEC5A, SOX4, WLS, POSTN, PRKCE, F2R, GOLPH3L, MIF, HLA-E, ADAM9, ADAM8, CLEC4E, CFTR, BLK, CD274, CSF1R, TWIST1, GATA3, PRKCZ, RASGRP1, TMEM27, NLRP3, CD14, MYH10, TGFB2, TGFB1, FZD5, CRTAM, IGF1, IL6, ACHE, ORM1, LRRK2, PTPN22, ARRB1, IFIH1, CD38, FFAR2, CD34, HAVCR2, IL10, CHUK, SYK, DDX58, RIPK2, IL17RB, MMP12, TLR1, FGR, IL1A, IL1B, IGHD, TLR8, TLR4, TLR2, EXOC1, NOD2, CD58, CCL19, APBB1, IL33, NR1H2, NR1H4, MAPK14, CD2, NLRP12, F2RL1, CD244, IL17A]
GO:0034504;protein localization to nucleus;6.0;0.7192862368539868;0.682763431017138;8.763526815005518;32.77360880529348;4.8942717050940985;0.001096903192380182;0.5734135951955668;[NUP107, CSE1L, HHEX, XPO1, NUP62, NUP133, SYK, TSC2, MMP12, NUP54, NUP85, NUP88, RANBP2, RANBP1, NUP155, PLK1, RANBP6, PML, COL1A1, PIKFYVE, NUP35, RAN]
GO:0070208;protein heterotrimerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;7.212124270218933;0.002859955186148837;0.7197477358342742;[COL1A1, COL1A2, COL6A2, NUP62, COL6A1, NUP54]
GO:0021828;gonadotrophin-releasing hormone neuronal migration to the hypothalamus;11.0;1.0;0.9324289523296623;9.628524252492122;88.9737192139704;9.083926447120524;0.002977870310942956;0.8969813732811862;[NRP1]
GO:0036486;ventral trunk neural crest cell migration;8.0;1.0;0.875;9.628524252492122;24.653414450138296;8.67846133901236;8.251275950136018E-4;0.8188169164668168;[NRP1]
GO:2000251;positive regulation of actin cytoskeleton reorganization;9.0;1.0;0.896240625180289;9.628524252492122;130.7363647434596;6.8867018697843045;0.004375628472874139;0.7484268790654467;[NRP1, HCK, CSF3, FES, NTF3, STAP1, HCLS1, TEK]
GO:1903375;facioacoustic ganglion development;6.0;1.0;0.8231203125901445;9.628524252492122;32.51846529594618;9.083926447120524;0.0010883637687365787;0.7876727335416686;[NRP1]
GO:1902287;semaphorin-plexin signaling pathway involved in axon guidance;8.0;1.0;0.875;9.628524252492122;28.581916314885376;7.292166977892469;9.566110170045473E-4;0.747921758369865;[NRP1, PLXND1, PLXNB2]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, PRF1, TCL1A, DPYSL3, TNFSF11, TGM2, MIF, OLFM4, CLDN3, KCTD12, KCTD15, BLM, MGST1, ITPR3, ACAT1, CD79B, CD79A, NACC2, HMOX1, ECT2, VASP, CAV1, EHD3, DPYS, CD3G, CD3E, CD3D, ALAD, EMILIN1, TK1, FCER1G, KCND2, VWF, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, RXRA, POLQ, GCH1, SOD2, MARCKS, RAD51, P2RX1, IMPDH2, GOPC, CD247, RBMX]
GO:0048008;platelet-derived growth factor receptor signaling pathway;8.0;0.7763722522362496;0.7631861261181248;9.186691500213083;31.002284443533863;6.280566066213989;0.0010376185600805164;0.6961884407023742;[PDGFRB, NRP1, PDGFRA, PDGFA, PIK3C2A, PDGFRL, NR4A3, PDGFD, PDGFC]
GO:1900024;regulation of substrate adhesion-dependent cell spreading;7.0;0.8933024483968273;0.7975705894556142;9.485423408851448;77.8386910509756;5.905872616772578;0.002605190939202256;0.6529459655301135;[DOCK5, NRP1, TACSTD2, FBLN1, PDPN, FLNA, POSTN, ACTN4, OLFM4, PTK2, DNM2]
GO:0007265;Ras protein signal transduction;7.0;0.7586651285174919;0.7302519295159464;8.935377071932177;27.526979089716047;4.2636448815154875;9.213032174599934E-4;0.5689623627776663;[CYFIP1, CELSR1, EPS8, GRAP2, ARHGDIA, ARHGDIB, RAB32, DOK2, DOK3, RAB31, AGTR1, DNMT1, IQGAP3, RASGRP1, RRAS, G3BP2, JUN, HACE1, PLK2, DHCR24, IGF1, COL1A2, BCL6, CDK2, LAT, GPSM2, CDKN1A, ARHGAP6, ARHGAP4, RAC2, ARHGEF12, CHUK, RHOG, RHOH, RHOC, RAB33B, CCNA2, RHOU, AIF1, RAB21, PAK1, NRAS, PDPN, EPS8L1, EPS8L3]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[HP, TNFAIP3, ETS1, SLC8A1, AQP1, IL18RAP, MYB, CYP1B1, PDGFRB, ANXA1, GPX1, DUSP1, ARG1, PRKCD, SIRT1, PAX2, ADAM9, HDAC2, PCNA, KCNA5, FOXO1, CST3, PDGFD, HMOX1, ECT2, JUN, STAT1, KLF4, MAPK13, COL1A1, FABP1, FOSL1, IL6, NR4A3, FKBP1B, CDK1, BCL2, SDC1, EZH2]
GO:1900026;positive regulation of substrate adhesion-dependent cell spreading;8.0;1.0;0.875;9.628524252492122;350.51777089970517;6.280566066213989;0.011731514346499779;0.6961884407023742;[DOCK5, NRP1, OLFM4, DNM2, FLNA]
GO:0007266;Rho protein signal transduction;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;29.60642063139588;5.334422371190153;9.9090025448413E-4;0.6478026081386739;[CELSR1, ARHGAP6, ARHGAP4, EPS8, PAK1, ARHGDIA, PDPN, ARHGDIB, RAC2, EPS8L1, EPS8L3, ARHGEF12, CHUK, RHOG, RHOH, RHOC, COL1A2, BCL6, AGTR1, RHOU]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[CALML4, UXT, CDC20, STMN1, FBXO5, MAP1B, KIF20A, LLGL2, PRKCZ, FIGNL1, CEP72, PLK2, PLK1, PTK2, TPX2, CETN3, KIF11, NUF2, TUBG1, KIFC1, KIF2C, CENPA, FLNA, RANBP2, RANBP1, CENPW, TUBE1, CENPE, TACC3, SPC25, CEP120, NUSAP1, NEK2, GAS2L3, MAP7D1, MAP7D2, CCNB1, STIL, NEK7, NDC80, KIF18A, KIF18B, FES, KIF4A, CDK1, GPSM2, MYBL2, NAV1, CKAP5, ASPM, PSRC1, ESPL1, BIRC5, BIRC2, BIRC3, VPS4B, TTK, AURKB, AURKA, POC1A, SPAG5, WEE1, PRC1, RAN]
GO:0046621;negative regulation of organ growth;6.0;0.811012628672052;0.7286266269261705;9.360260265897443;146.9345464739773;6.599019797332524;0.0049177670379774545;0.6605944919115335;[PTK2, PAK1, MEIS1]
GO:0048012;hepatocyte growth factor receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;7.292166977892469;0.0010376185600805164;0.747921758369865;[NRP1, PAK1, STMN1]
GO:0002521;leukocyte differentiation;4.0;0.5833093054345528;0.5416546527172764;7.409320768437127;21.066225782797595;4.174954806800768;7.050676185779127E-4;0.4635073829750448;[CSF3, SPI1, CSF2, TFRC, RORA, IKZF1, TNF, LGALS1, TNFSF11, JUNB, SOX4, TPD52, EOMES, MED1, MEF2C, IFNA14, RSAD2, IFNA16, FLT3LG, ATP11C, RUNX2, OSCAR, CLEC4D, TYROBP, MSH2, CD8A, PRTN3, CLEC4E, CARD11, IFNA10, EPHA2, CSF1R, BLM, PRKDC, TXK, TCF7, TNFRSF11A, GATA3, GATA1, CD79B, CD79A, SBNO2, FUT7, RRAS, PLCG2, NKX2-3, IFNA21, LYN, EGR1, JUN, TGFB1, VCAM1, BCL11B, FZD5, FZD8, BMX, PTPRC, MAFB, BCL6, BCL3, CD28, BCL2, IL7R, ITM2A, GPR18, IFNA5, IFNA4, ITK, IFNA7, IFNA2, PIK3CD, CD3G, TREM2, PTPN22, CD3E, IFNA8, CD3D, LYL1, HHEX, BLNK, CCR9, CCR7, CCR6, JAK3, IL10, CR2, ANXA1, FCER1G, ITGA4, IL15, NFAM1, RHOH, GAB2, MMP9, SIRT1, CBFA2T3, VAV1, ZAP70, LCK, TAL1, KIT, CDH17, CEBPA, CEBPE, LEF1, DLL1, RELB, TBX21, CCL19, SEMA4A, LILRB1, MAPK14, CD4, KLF6, CD40LG, CAMK4, DNAJA3, F2RL1, LTBR, FCGR2B, IL18R1]
GO:0051896;regulation of protein kinase B signaling;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;45.070113835906206;4.498958968449952;0.001508456149618737;0.580996336126719;[CD86, CSF3, CD80, TNF, FGF5, SESN3, AKT1, TNFSF11, PDGFRB, PDGFRA, IGFBP5, TSC2, EREG, BTC, ADAM8, EPHA2, PDGFA, GATA3, PIK3R5, PKHD1, RRAS, CD19, ICOS, TGFB1, PTK2, LIN28A, CD28, NOX4, HPSE, PIK3CD, ARRB2, CCR7, GPX1, GAB1, IL18, SIRT1, F3, VAV1, BANK1, LCK, KIT, CHI3L1, HCLS1, HBEGF, ENG, THBS1, FYN, CCL19, CCL21, TRAT1, EGF, KLF4, KITLG, TEK]
GO:0048010;vascular endothelial growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.186691500213083;31.002284443533863;5.572381008289503;0.0010376185600805164;0.6599718239061428;[CYFIP1, NRP1, NRP2, NCF1, NCF2, ITGB3, NCF4, CYBB, VAV1, SH2D2A, NCKAP1L, FYN, MAPK14, SULF1, PTK2]
GO:0051893;regulation of focal adhesion assembly;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;59.47724087459839;5.769740442447999;0.0019906497260312257;0.6459841598043611;[NRP1, THY1, ARHGAP6, THBS1, EPB41L5, PTK2, GREM1, DLC1, TEK, EPHA3]
GO:0051894;positive regulation of focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;280.4986055833795;6.599019797332524;0.009388035896519984;0.712474179321389;[NRP1, EPB41L5, TEK, THY1]
GO:0032956;regulation of actin cytoskeleton organization;7.0;0.559792591703537;0.630815661108969;7.718981747607684;34.11626247365944;3.9689311377000256;0.0011418406023505395;0.553890688213353;[CYFIP1, CSF3, CELSR1, F11R, CTGF, ICAM1, PYCARD, EPS8, ARHGDIA, STMN1, ARHGDIB, ARFIP1, PDGFRB, TMOD1, PDGFRA, MEF2C, PRKCE, TPM1, PRKCD, PFN1, EPHA3, CSF1R, TACSTD2, PDGFA, CORO1A, SPTA1, STAP1, NCKAP1L, VASP, TGFB1, VIL1, BST1, CXCL12, FES, JMY, ID1, NOX4, NRP1, PLEK, LMOD1, ARHGEF10L, ARHGAP6, CCR7, SPTAN1, EDN1, RHOG, RHOH, ARAP1, RHOC, SPTB, CIT, HCK, TMEFF2, HCLS1, RHOU, SHANK3, LRP1, SYNPO2, CAPG, PAK1, NTF3, EPS8L1, FLNA, EPS8L3, JAM3, GSN, CCL21, DLC1, F2RL1, TEK]
GO:0051496;positive regulation of stress fiber assembly;11.0;1.0;0.9324289523296623;9.628524252492122;365.07497849775285;5.926926025970411;0.012218730984170163;0.735532224928036;[NRP1, ARHGEF10L, CTGF, PAK1, TPM1, NOX4]
GO:0071364;cellular response to epidermal growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.088194173566533;0.003262744749111514;0.63447084575632;[MCM7, AKT1, PLCG1, MED1, CAD, PAX2, COL1A1, VIL1, ID1, SNAI2]
GO:0048013;ephrin receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[EPHB2, EPHB1, AP2M1, MMP2, MMP9, EPHA3, EPHA2, SDC2, PAK1, FYN, LYN, PTK2]
GO:0051017;actin filament bundle assembly;6.0;0.7866048967936545;0.7164227609869718;9.143016436710422;39.792633402144126;5.734022359845919;0.001331823628924752;0.6163584827319739;[ITGB5, ARRB1, AIF1, EPS8, DPYSL3, PLS1, ACTN1, PAWR, ACTN4, SORBS1, RHOC, MARCKS, ZYX, LCP1]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CSF3, CD80, PIK3CD, ARRB2, TNF, FGF5, TNFSF11, CCR7, PDGFRB, PDGFRA, GPX1, IGFBP5, GAB1, IL18, F3, VAV1, EREG, BTC, LCK, KIT, CHI3L1, HCLS1, ADAM8, HBEGF, ENG, PDGFA, GATA3, THBS1, PIK3R5, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK, HPSE]
GO:0071526;semaphorin-plexin signaling pathway;6.0;0.811012628672052;0.7286266269261705;9.089527751759436;26.50247477320489;6.166155715036245;8.87013979980389E-4;0.6384578026126634;[NRP1, SEMA5B, SEMA4A, NRP2, SEMA6A, PLXND1, SEMA4B, ARHGDIA, FLNA, PLXNB2]
GO:0060385;axonogenesis involved in innervation;9.0;1.0;0.896240625180289;9.628524252492122;65.99544162831262;8.16763571524637;0.0022088080392582156;0.8139338954918922;[NRP1]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MED1, MEF2C, PRKCH, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PRKDC, PDGFA, IQGAP3, GATA1, PRKCZ, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, MCTS1, JUN, FN1, CDC7, CDC6, FOSL2, FOSL1, NOX1, CDKN1A, ADM, HOXC10, TIMP1, JAK3, HLA-DPA1, HAVCR2, ANXA1, ARG1, RIPK2, FCRL3, EMP2, SIRT1, F3, PAX2, MMP12, RARA, HCLS1, HBEGF, PTAFR, KCNA5, PTGS2, NRAS, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, STAT1, LRG1, HLA-DPB1, CSF3, CHRM1, CSF2, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, PPP1R16B, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, DNMT1, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, CDK6, BCL6, CDK2, CDK1, BCL2, HPSE, BCL2L1, ITGB3, FASLG, ARRB1, FOXM1, CYR61, TNFSF13B, LBH, ITGA4, ASPM, XCL1, BIRC5, CX3CR1, HDAC2, SMARCD3, TTK, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, PML, KLF5, PRC1, DNAJA3, IL2RA, PTPN6, CCNF, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, TIPIN, FLT3LG, MIF, RUNX2, EREG, HLA-E, BTC, SFRP2, IL23A, KIF20B, EBI3, TGFA, TWIST1, CD1D, PKHD1, SLAMF1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, IGF1, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, KIF14, PRL, CD3E, BMI1, ESM1, RAC2, CTSH, CD38, CCR3, CCR2, IL10, EDN1, SYK, IL15, RHOG, IL18, PDCD1LG2, AVPR1A, GAB2, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, AIF1, GNAI2, CST3, PURA, PAK1, CXCR2, CD74, CDX2, OSM, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IHH, ETS1, IL6R, TGM2, PDGFRB, GHSR, PDGFRA, MATK, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, HTRA1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, IL7R, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, TBC1D8, MMP9, TGFBR3, CCNA2, GREM1, ZAP70, IFNG, NDUFS4, LTA, LTF, LEF1, DLL1, THBS1, HLX, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, RPS6KB1, TEK]
GO:1902336;positive regulation of retinal ganglion cell axon guidance;12.0;1.0;0.9481203125901445;9.628524252492122;1458.3969986044274;9.083926447120524;0.04881123507120434;0.9126727335416687;[NRP1]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[IL1RN, GOLT1B, TNF, LGALS1, AKT1, TNFSF11, TRIM25, WLS, TGM2, PRKCB, PRKCE, F2R, CARD11, S100A12, HMOX1, ECT2, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, CD40, SECTM1, FASLG, NUP62, CCR7, CD36, CHUK, RIPK2, RHOC, ZDHHC17, IL1B, TLR6, BIRC2, LTF, BIRC3, NOD2, FLNA, FYN, CCL19, CD74, CCL21, CARD9, CD4, F2RL1, LTBR]
GO:0150020;basal dendrite arborization;10.0;1.0;0.9152410118609203;9.628524252492122;197.41096074002914;8.67846133901236;0.006607167197638665;0.8590579283277371;[NRP1]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[CYFIP1, CD3G, IGHG1, FCGR3A, SYK, PRKCE, PRKCD, VAV1, FGR, HCK, PAK1, IGKC, IGLV1-44, PLCG2, NCKAP1L, FYN, PLCG1, FCGR1A, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0060301;positive regulation of cytokine activity;8.0;1.0;0.875;9.628524252492122;129.14918693253554;9.777073627680469;0.004322507059909803;0.875;[NRP1]
GO:0001890;placenta development;4.0;1.0;0.75;9.628524252492122;49.86610466882393;6.193554689224359;0.0016689736466849693;0.5667386748366816;[ABCB4, CCNF, HTRA1, MAPK14, ASCL2, PTK2, DCN, PHLDA2, E2F7, BIRC2, E2F8]
GO:0045667;regulation of osteoblast differentiation;5.0;0.8259837884571596;0.7032329060895001;9.405380701177911;40.22549681874724;5.067543426368135;0.001346311177926675;0.5493954183502558;[IFITM1, TNF, CYR61, HOXA2, IL6R, MEN1, MEF2C, IGFBP5, AXIN2, RUNX2, GREM1, SFRP2, FAM20C, LTF, HEMGN, CEBPA, CEBPB, TWIST1, CTHRC1, JAG1, TMEM64, IGF1, PTK2, IL6, BMP2, CDK6, ID1, SNAI2]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, BTG2, KIF14, ARRB1, ARRB2, CHL1, MEF2C, F2R, MSH2, ADAM8, NAIP, CEBPB, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, HMOX1, FYN, SNCA, JUN, WFS1, GABRA5, SOD2, POU4F1, NR4A2, NR4A3, BCL2, BCL2L1]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[CSF2, IL5RA, TNF, FGF5, TNFSF11, MAP3K8, MEN1, PDGFRB, MEF2A, PDGFRA, MED1, MEF2C, MAP2K2, PAQR3, EREG, BTC, TRIB1, PDGFA, CSF2RB, RASAL2, IQGAP3, CSF2RA, RASGRP1, RASGRP4, SPTA1, MAP2K6, TGFB1, IGF1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, JAK3, MAP4K1, CHUK, RIPK2, STRADB, IL18, GFRA3, SPTB, DUSP6, IL1B, KIT, IL3RA, SHANK3, HBEGF, CAMK2D, NOD2, IL2RG, NRAS, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, MAPK13, KITLG, IL2RA, IL2RB, TEK]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[NRP1, ITGAM, ITGB5, ITGB4, ITGB3, ITGA2B, ITGB2, PLEK, ITGAL, CTGF, ADAMTS1, ITGAX, ITGB8, ITGB7, ITGB6, FCER1G, SYK, ITGA4, VAV1, FGR, HCK, CEACAM1, TYROBP, ADAM9, ITGA7, TLN1, CDH17, TXK, THY1, PTK2, COL3A1, ZYX, PLP1, LAT]
GO:2000811;negative regulation of anoikis;8.0;1.0;0.875;9.628524252492122;103.9210822679579;6.943860283624253;0.0034781451006065307;0.7301093378270707;[CAV1, PTK2, CEACAM6, CEACAM5, BCL2, SNAI2]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, JUNB, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, JAK3, HLA-DPA1, ANXA1, SERPINB2, IFNGR1, GPR35, RIPK2, IFNGR2, BGN, FOS, SIRT1, F3, FCER2, ZEB1, PLCB1, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, STAT1, IL10RA, HLA-DPB1, PF4, CSF3, CSF3R, CSF2, F13A1, IL5RA, RORA, CXCL13, TNF, PYCARD, IGHG1, MAP3K8, IL13RA2, IL13RA1, IFNA14, CISH, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, CD300LF, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, BCL2, HLA-DRA, MYD88, BCL2L1, CIITA, ITGAM, ITGB2, PIK3CD, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL2, XCL1, BIRC5, LCP1, BIRC2, BIRC3, CX3CR1, CEBPA, CEBPD, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, IL21R, CCL2, CCL1, FYN, FCGR1A, FCGR1B, PML, KLF6, IL2RA, IL2RB, PTPN6, IL1RN, IFITM1, IFI30, IFIT1, IFIT3, IFIT2, ICAM1, TNFSF11, TRIM25, IL15RA, RSAD2, ACSL1, IL1R1, IL1R2, HLA-B, FLT3LG, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IFI27, IL23A, EBI3, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, CD27, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR3, CCR2, IL10, SYK, IL15, IL18, GP1BA, GAB2, IL17RB, VAV1, HCK, IL1A, CEACAM1, IL1B, KIT, RHOU, SP100, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR3, CXCR2, IL32, CD74, IL33, OSM, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, CSF2RA, TGFB1, VCAM1, ISG15, NFKBIA, IL6, IL7R, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, OASL, LMNB1, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, OAS1, OAS3, LTA, IRF7, IRF8, LTB, CAMK2D, SAMHD1, NCAM1, MX2, SOD2, CD4, LTBR]
GO:0000281;mitotic cytokinesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;28.615093046006976;5.649939242635378;9.577214123380678E-4;0.5791791674783379;[BRCA2, CENPA, RACGAP1, STMN1, NUSAP1, ECT2, MYH10, CEP55, CDT1, PLK1, CKAP2, KIF23, RHOC, CIT, ANLN, ESPL1, KIF4A, KIF20A]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[TNC, IHH, FHL2, CYR61, FBL, AKT1, JUNB, MEF2C, TPM4, IGFBP5, IGFBP3, RUNX2, VCAN, COL6A1, EPHA2, LEF1, HSD17B4, TWIST1, GPNMB, FIGNL1, SPP1, HSPE1, COL1A1, BMP2, PSMC2, ALPL, SNAI2, RBMX, LGR4]
GO:0034446;substrate adhesion-dependent cell spreading;6.0;1.0;0.8231203125901445;9.628524252492122;56.23121614310476;6.088194173566533;0.0018820081995007299;0.63447084575632;[NRP1, ITGA4, ITGB3, FN1, KIF14, LAMB1, LAMC1, PARVB, ANTXR1, ITGB7, TEK]
GO:0038007;netrin-activated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;7.697632086000634;8.87013979980389E-4;0.7167775754447168;[DCC, PTK2]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD40, CSF3, CSF2, NCF1, CD80, ITGB3, IFNA2, TREM2, ARRB2, CD3E, ICAM1, GHR, GRM5, CD36, IL6R, SYK, RIPK2, IL15, IL18, MIF, PARP9, EREG, GREM1, IFNG, BANK1, IL23A, KIT, HCLS1, HBEGF, CSF1R, HDAC2, TGFA, GATA1, CCL5, NTF3, STAP1, FYN, LYN, CD74, TGFB1, ACE, EGF, LIF, OSM, IGF1, GH1, CD4, IL6, CSPG4, CD24]
GO:2001224;positive regulation of neuron migration;8.0;0.8933024483968273;0.8216512241984136;9.59462270081644;536.247192550588;7.138016298065211;0.017947710943527356;0.7400384854347593;[SEMA6A, FLNA, KIF20B]
GO:0044344;cellular response to fibroblast growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.444869117505266;0.003262744749111514;0.6527112189764278;[POSTN, EGR3, COL1A1, NR4A1, CCL5, CCL2, SNCA]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[BLK, ITK, TXK, SLA, SLA2, GRAP2, FYN, CSK, JAK3, LYN, SYK, MATK, BMX, PTK2, FGR, ZAP70, HCK, LCK, FES, BTK]
GO:0048666;neuron development;4.0;0.6696747006330769;0.5848373503165385;8.088079211544972;32.15320660831846;4.814228997420562;0.001076138889173156;0.4961998948126311;[ROBO2, GABRB1, BTG2, FMR1, IHH, DPYSL3, MEF2C, ETV1, THY1, NPY, TGFB2, FZD2, GABRA5, LIF, POU4F1, SLC4A7, UQCRQ, GNAQ]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CD40, AQP1, CHEK1, AKT1, CASP2, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, CASP8AP2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:1902618;cellular response to fluoride;5.0;1.0;0.7902410118609202;9.628524252492122;70.21110216540774;9.777073627680469;0.0023499024035866234;0.7902410118609202;[COL1A1]
GO:0097475;motor neuron migration;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;22.707504301080803;7.8311634786251565;7.599997335300838E-4;0.7236063770733796;[NRP1]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[LYN, ABCA1, YAP1, HDAC2, TNC, KLF4, PHB2, PAX2, AQP1, COL1A1, MYB, RARA, HOXA2, EPHA3]
GO:0035767;endothelial cell chemotaxis;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;58.99646552848538;7.474488534686424;0.0019745586078665435;0.7572456912631272;[NR4A1, NRP1, EGR3, CXCL13]
GO:0031960;response to corticosteroid;6.0;0.7140352122741334;0.6801379187272112;9.05316010758856;61.63829009254609;4.689477292448085;0.0020629780985379075;0.5629403994089356;[CDKN1A, IL1RN, SPARC, ADM, TNF, CTGF, AQP1, ICAM1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, CYBB, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, ENG, PCNA, FECH, ABCB4, PTAFR, PTGS2, TYMS, AIF1, FOXO1, IGFBP7, TGFB1, COL1A1, FOSL1, IL6, RPS6KB1, BCL2, ALPL, SDC1, FOSB]
GO:2001237;negative regulation of extrinsic apoptotic signaling pathway;9.0;0.8436909121759173;0.8180860812682478;9.50592193039979;358.6811287979994;5.152100814396198;0.012004734588810557;0.6597193004257005;[NRP1, CSF2, SERPINE1, HMGB2, TNFAIP3, FASLG, BRCA1, TNF, ICAM1, LGALS3, AKT1, GPX1, DAPK1, STRADB, IL1A, SFRP2, IL1B, ZMYND11, CX3CR1, YAP1, IFI6, THBS1, GATA1, CTNNA1, HMOX1, FYN, TNFRSF10B, IGF1, RPS6KB1, BCL2, SNAI2, PF4, BCL2L1]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, ICAM1, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, SIRPA, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, DOK2, PRTN3, ADAM8, S100A9, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, FUT7, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, ESAM, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, PIK3CD, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, IL10, ANXA1, FCER1G, SYK, ITGA4, MMP1, PDE4D, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, SLC7A9, IL1B, CEACAM5, KIT, PECAM1, XCL2, XCL1, CD48, CEACAM8, CX3CR1, CCL13, SELPLG, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR3, TBX21, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CD74, CCL23, CCL21, CCL20, CD2, NLRP12, F2RL1, PTPN6, TEK, CD244, PF4]
GO:0030199;collagen fibril organization;5.0;1.0;0.7902410118609202;9.628524252492122;53.964823970696955;5.9928839937622085;0.0018061540931107725;0.5967173779995258;[TGFB2, COL14A1, LUM, COL11A1, COL12A1, LOXL2, COL1A1, GREM1, COL3A1, SFRP2, COL1A2, COL5A1, LOX, COL5A2, CYP1B1]
GO:0001938;positive regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.3065775231622;5.277263957350204;0.0029220725788817177;0.6207988894539612;[NRP1, NRP2, ECM1, ITGB3, HMGB2, NRAS, AKT1, HMOX1, PLCG1, CCR3, IL10, PPP1R16B, GHSR, JUN, EGR3, ITGA4, ARG1, CAV2, TNFSF12, SIRT1, F3, NR4A1, BMP2, LRG1, CXCL12, AGTR1, TEK]
GO:0035924;cellular response to vascular endothelial growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;62.59148538135601;6.599019797332524;0.00209488068703431;0.6605944919115335;[NR4A1, NRP1, EGR3, ANXA1, VCAM1, AKT1, GAS1, MAPK14]
GO:0071306;cellular response to vitamin E;8.0;1.0;0.875;9.628524252492122;314.0784094220964;9.083926447120524;0.010511921711140423;0.839552420951524;[COL1A1]
GO:0106089;negative regulation of cell adhesion involved in sprouting angiogenesis;10.0;1.0;0.9152410118609203;9.628524252492122;300.53542469799993;9.777073627680469;0.01005865020031986;0.9152410118609203;[SEMA6A]
GO:0007172;signal complex assembly;6.0;1.0;0.8231203125901445;9.628524252492122;86.36830501999869;7.697632086000634;0.002890669442591265;0.7167775754447168;[CD3E, PTK2]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[TGFA, SLC30A10, PIK3C2A, EPS8, EFEMP1, REPS2, AKT1, PLCG1, TGFB1, EGF, GAB1, PTK2, EREG, BTC, VIL1, KIF16B, FES, HBEGF]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[ITGB5, PTPRK, ARRB2, F11R, CDH5, FOS, SIRT1, TGFBR3, ADAM9, LTBP2, PRKCZ, JUN, TGFB2, TGFB1, USP9Y, PTK2, PML, COL3A1, COL1A2, ID1, ZYX]
GO:0002042;cell migration involved in sprouting angiogenesis;9.0;1.0;0.896240625180289;9.628524252492122;27.169092758590633;7.069023426578259;9.093250840340128E-4;0.757750811958709;[GREM1, NR4A1, NRP1, EGR3]
GO:0043542;endothelial cell migration;7.0;0.7980440201809971;0.7499413753476991;9.143016436710422;24.971868181253015;5.71663061713405;8.357859548042604E-4;0.6432681208679463;[NRP1, PLXND1, ITGB2, CXCL13, LOXL2, DPP4, CYP1B1, PRSS3, EGR3, GPX1, TNFSF12, EMP2, PTK2, GREM1, NR4A1, FAP, ID1, S100P]
GO:0006887;exocytosis;6.0;0.6696747006330769;0.657957662906683;8.375761283996754;37.082880499217325;3.1596706497059923;0.0012411306378830758;0.4847060165558207;[, CDA, CYFIP1, SERPINE1, ABCA13, PSMD3, C3AR1, PRSS3, PGLYRP1, PRKCD, RNASE3, RNASE2, BIN2, PADI2, SERPING1, CFD, FPR1, PDGFA, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, LYN, JUP, FUCA1, FN1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, TIMP3, TIMP1, ANXA3, ARG1, NFAM1, ANXA5, F5, PSMA5, PSMA2, EXOC1, SERPINB10, GRN, PTAFR, NRAS, ALOX5, FLNA, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, PF4, ATP8A1, PROS1, ITGA2B, HP, F13A1, APEH, CLU, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, LIN7A, GPR84, CORO1A, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, COPS5, PTPRC, LCN2, HPSE, LAT, ITGAM, ITGB3, ITGB2, PIK3CD, ITGAL, PIK3C2A, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, VWF, NDUFC2, TNFRSF1B, NPC2, PECAM1, BPI, ACPP, FGL2, CCL8, TTR, CCL5, PCDH7, CPPED1, FCGR2A, P2RX1, IMPDH2, VPS41, PTPN6, MNDA, FOLR3, SPARC, LGALS3, ANPEP, ACTN1, SLC11A1, ACTN4, MIF, ANK1, CHIT1, SLPI, CRISPLD2, TLN1, LLGL2, STXBP2, MGST1, CD14, A2M, CCR1, PRG2, NBEAL2, PPBP, IGF1, BST1, TF, VNN1, ORM1, ECM1, CTSZ, CTSW, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CTSD, CAMP, CD33, CTSB, CD53, CCT2, FCER1G, MME, GAA, RHOG, LAT2, HCK, CEACAM1, CEACAM6, KIT, CEACAM8, TLR2, LILRA3, STX11, CST3, PAK1, CXCR1, CXCR2, CD58, CCT8, GCA, LHFPL2, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, CD300A, APLP2, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, RASGRP1, MYH10, MGAM, TGFB2, TGFB1, SYT2, HSPA6, GGH, SELP, NR4A3, SELL, MS4A3, TNFAIP6, CRISP3, PLEK, TNFAIP2, CXCL1, SIRPB1, HK3, PLAUR, MMP8, SYNGR3, MMP9, FGR, MMRN1, CHI3L1, DOCK2, LTF, CLEC12A, RETN, THBS1, EGF, MAPK14, CD9, S100P, PTX3]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[F11R, ICAM1, TIAM2, DEPDC1B, RIN2, LLGL2, EPHA2, THY1, RACGAP1, NCKAP1L, A2M, JUN, EZH2, ARHGAP9, DENND1B, NRP1, CD40, ARHGAP6, ARHGAP4, CCR7, RHOG, GMIP, VAV1, DEPDC1, PLCB1, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL21, CCL20, DLC1, F2RL1, SIPA1, CXCL13, RGS1, ARHGDIA, ARHGDIB, F2R, TSC2, ADCYAP1, ACAP1, PRTN3, ARHGAP19, RASAL2, ARHGAP15, RASGRP1, ADAP2, ECT2, EVI5, CAV2, ARHGAP25, TBCK, ARHGAP30, GNAQ, ARHGAP11A, DOCK4, LRRK2, ARRB1, TAGAP, ARHGEF12, TBC1D8, TBC1D9, ARAP3, ARAP1, AXIN2, ALDH1A1, XCL2, XCL1, DOCK2, ASAP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0010977;negative regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;494.1264199049594;4.793467005972133;0.016537966589312465;0.6413787507847162;[NRP1, SEMA5B, LRRK2, GFI1, CTSZ, ARHGAP4, LGALS1, ARHGDIA, DPYSL3, TNR, CD38, EPHB2, YWHAH, SEMA6A, DCC, PAQR3, RGMA, NLGN1, HDAC2, LRP1, RNF6, THY1, SPP1, LINGO1, SEMA4A, PLK2, SEMA4B, PTK2, ID1, PMP22, ITM2C]
GO:0055003;cardiac myofibril assembly;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;125.46400130584401;6.641579411751319;0.0041991672134361795;0.7146506799819907;[PDGFRB, MEF2A, PDGFRA, MYH10]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, DPYSL3, ADCYAP1, MAP1B, S100A9, EPHA3, NEDD4L, LYN, FZD1, SYT2, FN1, CXCL12, FES, PLXNB2, EZH2, ROBO2, NRP1, NME1, SHANK3, NLGN1, RAB21, PAK1, CNR1, FYN, APBB1, FKBP1B, CAMK1]
GO:0010613;positive regulation of cardiac muscle hypertrophy;8.0;0.8933024483968273;0.8216512241984136;9.485423408851448;95.57844489853944;6.444869117505266;0.003198924535738274;0.7045909063862833;[MEF2A, CAMK2D, EDN1, TRPC3, IGF1, PTK2, NR4A3, PDE5A]
GO:0032489;regulation of Cdc42 protein signal transduction;10.0;1.0;0.9152410118609203;9.628524252492122;50.14528765113853;7.8311634786251565;0.0016783176498546674;0.8157270763441555;[ABCA1, NRP1]
GO:0051964;negative regulation of synapse assembly;7.0;0.8259837884571596;0.7639112594857803;9.437469015729413;219.30269939314178;7.9853141584524145;0.007339863989072673;0.7592887026755414;[ROBO2, PTK2, TLR2]
GO:0060396;growth hormone receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;7.292166977892469;0.0010376185600805164;0.747921758369865;[GHR, SOCS2, GH1, PTK2]
GO:0010594;regulation of endothelial cell migration;8.0;0.7307253602413294;0.7403626801206646;9.253830803050711;53.61991368545132;4.793467005972133;0.0017946102562627052;0.620138125604427;[NRP1, NRP2, CD40, SPARC, ITGB3, CXCL13, PIK3C2A, ETS1, AKT1, MEF2C, EDN1, ANXA1, ANXA3, EMP2, SIRT1, DCN, CEACAM1, EPHA2, SP100, GATA3, PTGS2, THBS1, HMOX1, PLCG1, SEMA4A, TGFB1, JUP, PLK2, NR2F2, KLF4, PTK2, TEK]
GO:0150018;basal dendrite development;7.0;1.0;0.8509193652572005;9.628524252492122;34.02047363004817;9.777073627680469;0.0011386346359592329;0.8509193652572005;[NRP1]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRA, EDNRB, GPR171, C3AR1, AKT1, PROK2, HOMER3, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, EREG, TIAM2, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, PIK3R5, C3, GNG10, OR7D2, CCR10, CCR1, ABCA1, FZD1, GPR15, FZD2, FZD5, OR2J2, FZD8, AZU1, NMBR, PPBP, GNG11, MARCO, PNOC, CALM3, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, ADM, CD3E, AKAP12, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR3, CCR2, EDN1, GPR37, ANXA1, GPR35, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, RHOC, VAV1, MC3R, PLCB1, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR3, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, F2RL1, RAMP1, LGR4, F2RL3, PF4, CHRM2, FCN1, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, CISH, SPNS3, APLP2, F2R, NPY1R, DGKZ, PDGFRL, ADCYAP1, SPNS1, OR2C3, GNAZ, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, ITPR3, GPR84, ADRB2, GPR82, HRH4, PSAP, ECT2, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, GNAQ, OR7E24, TAS2R7, CXCL6, GPSM2, CXCL9, OR1G1, PLEK, CXCL1, ARRB1, ARRB2, CXCL3, CXCL2, CXCL5, LTB4R, GRM5, CA2, PDE4B, PTGIR, ARHGEF12, PDE4D, GLP2R, OR2H1, XCL2, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, GNA15, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[YAP1, LRRK2, RUVBL1, SOX4, WLS, JUP, EGF, CAV1, AXIN2, NFKB1, SULF2, COL1A1, SFRP4, ASPM, SFRP2, DAAM2, LGR4, NAIP]
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;732.6859750532908;6.375876246018314;0.024522340210466318;0.7584915600596062;[LYN, PDGFRB, PDGFRA, TGFB1, CCL21, FPR2, NOD2, PTK2, FGR, KIT, CCR7, TEK, CCL19]
GO:0048843;negative regulation of axon extension involved in axon guidance;12.0;1.0;0.9481203125901445;9.628524252492122;2931.023726508963;6.558197802812269;0.09809872637615838;0.7835068532133509;[NRP1, SEMA5B, SEMA4A, SEMA6A, SEMA4B]
GO:0038063;collagen-activated tyrosine kinase receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;57.50475921673876;7.474488534686424;0.0019246325400609058;0.7572456912631272;[COL1A1, SYK, COL4A2, COL4A1]
GO:0048842;positive regulation of axon extension involved in axon guidance;12.0;1.0;0.9481203125901445;9.628524252492122;2927.4139206492227;7.8311634786251565;0.09797790942264722;0.8486063770733797;[NRP1, CXCL12]
GO:0006930;substrate-dependent cell migration, cell extension;6.0;1.0;0.8231203125901445;9.628524252492122;58.56724312331254;7.474488534686424;0.001960192920240494;0.7053660038532718;[NRP1, MYH10]
GO:0043434;response to peptide hormone;6.0;0.6696747006330769;0.657957662906683;8.712233520617966;71.32532737153224;4.149452513989832;0.0023871945184980284;0.5353235071248601;[CYFIP1, SPARC, CTGF, ICAM1, EDNRB, SESN3, AKT1, PRKACB, MEN1, GHSR, LHCGR, IGFBP5, PRKCD, CYBB, EREG, POR, ADCY9, RAB31, PRKAR1B, PRKDC, ABCB4, SLC30A10, FOXO1, BRIP1, PRKAR2B, CYC1, LYN, EGR1, EGR2, EIF2B3, TGFB1, CAV1, GGH, CDC6, NFKB1, NR4A2, COL1A1, NR4A1, CXCL12, NR4A3, FBN1, BTG2, ADM, HHEX, TIMP1, IL10, EDN1, ANXA1, ARG1, GLP2R, CAD, SIRT1, TGFBR3, CCNA2, CEACAM1, IL1B, TLR2, RETN, PTGS2, GNAI1, PAK1, PLN, FYN, CSK, SORT1, STAT1, SORBS1, TSHR, RPS6KB1, TEK]
GO:0048846;axon extension involved in axon guidance;6.0;1.0;0.8231203125901445;9.628524252492122;104.6753254820163;7.697632086000634;0.003503388942206243;0.7167775754447168;[NRP1, NRP2, ALCAM]
GO:0071560;cellular response to transforming growth factor beta stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;5.788089581116195;0.003262744749111514;0.6191234829421188;[CX3CR1, HDAC2, EPB41L5, PDGFD, FYN, MEF2C, EDN1, POSTN, TGFB1, ARG1, CAV1, COL1A1, COL4A2, NOX4, XCL1, FBN1]
GO:0001755;neural crest cell migration;6.0;0.7980440201809971;0.722142322680643;9.089527751759436;22.57397290845719;5.825829909099042;7.555305579894227E-4;0.6210535250702663;[NRP1, SEMA5B, SEMA4A, SEMA6A, SEMA4B, LEF1, TWIST1, EDNRB]
GO:0051056;regulation of small GTPase mediated signal transduction;7.0;0.6799073451904818;0.6908730378524415;8.647694999480395;45.070113835906206;4.018171853803189;0.001508456149618737;0.5564088607247961;[EPS8, ARHGDIA, STMN1, ARHGDIB, EPHB2, PDGFRB, F2R, TSC2, TIAM2, DEPDC1B, ARHGAP19, RASAL2, ARHGAP15, RASGRP1, RASGRP4, RACGAP1, ECT2, A2M, ABCA1, TGFB2, IGF1, ARHGAP25, ARHGAP30, BCL6, GPR18, ARHGAP9, ARHGAP11A, NRP1, KIF14, ARHGEF10L, ARRB1, FOXM1, ARHGAP6, ARHGAP4, NUP62, PSD3, TAGAP, RAC2, TIMP2, RALGPS2, PLEKHG1, ARHGEF12, GPR35, RHOG, ARAP3, RHOH, ARAP1, GMIP, RHOC, VAV1, DNM2, RHOU, FBP1, FGD3, FGD4, EPS8L1, EPS8L3, COL3A1, DLC1, F2RL1, SIPA1, F2RL3]
GO:0045860;positive regulation of protein kinase activity;10.0;0.6281612110245125;0.7293216173731766;9.003430535177193;1094.9224192180604;3.5309668621989068;0.03664606800502658;0.5958148214005239;[, IL1RN, CCNH, CCNC, TCL1A, AKT1, PROK2, TNFSF11, PRKACB, ACSL1, SLC11A1, PRKCD, MIF, EREG, PRKAR1B, IL23A, FPR1, TGFA, PDGFA, IQGAP3, PRKCZ, PIK3R5, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, EGR1, ACE, FZD5, GADD45B, FZD8, EIF2AK2, CDC6, AZU1, IGF1, PTK2, TPX2, NOX4, CALM3, CD24, EZH2, CDKN1A, CD40, KIF14, CCR7, MAP4K1, EDN1, SYK, RIPK2, STRADB, IL18, EMP2, SIRT1, DUSP6, MDFIC, IL1B, KIT, CKS2, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CD74, CCL21, CENPE, CD40LG, PKN1, CAMK1, CCNT2, NCF1, TNF, CLU, MAP3K8, IL6R, PDGFRB, MAP2K2, F2R, ADCYAP1, ADAM9, ADAM8, CSF1R, CALCA, C5AR1, TNFRSF11A, ADRB2, RASGRP1, CCNB1, STAP1, CLSPN, ECT2, DRD4, MAP2K6, TGFB2, TGFB1, TNFRSF10B, GH1, BMP2, PTPRC, CDK1, CSPG4, LAT, LRRK2, ITGB3, ARRB1, CYR61, CKS1B, GHR, GRM5, GREM1, PSRC1, IFNG, CHI3L1, LCP2, PDE5A, LTF, NOD2, THBS1, CCL5, FYN, CSK, SNCA, EGF, MAPK14, CD4]
GO:0010507;negative regulation of autophagy;7.0;0.7436939687323844;0.7227663496233927;9.117698628726131;217.48068666745357;5.500407508664414;0.007278882862848883;0.6322104610454062;[LRRK2, PTPN22, AKT1, TSC2, HMOX1, SNCA, PTK2, BCL2]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[IHH, BRCA2, ETS1, CTGF, RUVBL2, CD38, PDGFRB, IL10, GHSR, POSTN, ANXA1, DUSP1, TACR3, CCNA2, IL1B, RARA, PCNA, ABCB4, PTGS2, SOCS2, CST3, RBBP8, TGFB1, NR2F2, POU4F1, COL1A1, GH1, CD4, KIF18A, EZH2]
GO:0055015;ventricular cardiac muscle cell development;7.0;1.0;0.8509193652572005;9.628524252492122;69.56390858866273;7.379178354882098;0.002328241417009372;0.728290889492758;[CCNB1, CDK1, FHL2, MYH10]
GO:0030334;regulation of cell migration;6.0;0.4770562410916853;0.5616484331359872;7.1128459440373675;36.74126027361157;3.1319826581748256;0.0012296969163702938;0.48329005138129355;[SERPINE1, ADARB1, MYLK, DPYSL3, C3AR1, AKT1, CYP1B1, HOXA7, MEF2C, PRKCE, PADI2, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, KLRK1, FLRT2, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, JUN, JAG1, ACE, HACE1, JUP, PLK2, FN1, NR2F2, COL1A1, NOX4, SNAI2, GPR18, ARHGAP4, MMP28, TIMP1, ANXA1, ANXA3, EMP2, SIRT1, F3, TMEFF2, PLCB1, HBEGF, ENG, PTAFR, PTGS2, GPNMB, NTF3, FLNA, CCL19, JAM3, CCL21, CCL20, SULF1, COL3A1, PF4, SEMA5B, PLXND1, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, DACH1, PHLDA2, SEMA6A, IGFBP5, IGFBP3, F2R, TPM1, ADAM9, ADAM8, CD274, CSF1R, CD151, TACSTD2, CORO1A, CXCL10, CXCL11, DAB2, CXCL12, PTPRC, BCL2, PLXNB2, ITGB3, PIK3CD, PIK3C2A, CYR61, DUSP10, EMILIN1, ITGA4, XCL2, XCL1, CX3CR1, LRP1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, SEMA4A, SEMA4B, TIE1, KLF4, IL1RN, IFITM1, SPARC, ICAM1, LGALS3, IL1R1, ACTN4, MIF, SFRP2, IL23A, PFN1, TRIB1, KIF20B, NBL1, EPHA2, RRAS, CCR1, TNFSF14, PPBP, IGF1, PTK2, BST1, NRP1, PTPRR, NRP2, ECM1, CD40, KIF14, PTPRK, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, GAB1, RHOC, IL1A, CEACAM1, CEACAM6, IL1B, KIT, SGK1, SP100, AIF1, GNAI2, PAK1, CXCR3, CXCR2, PDPN, MPP1, CD74, IL33, PODN, DLC1, F2RL1, ETS1, PLAU, ARHGDIB, IL6R, PDGFRB, PDGFRA, POSTN, CD300A, VCL, C5AR1, STAP1, TGFB2, TGFB1, SELP, VIL1, IL6, BMP2, NR4A3, DOCK5, CXCL6, CXCL9, DOCK4, MCTP1, TNFAIP6, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, MYOCD, DDX58, ARAP3, MMP9, DCN, FGR, GREM1, IFNG, LAMA2, LAMA4, LAMA3, LEF1, THBS1, EGF, LAMB1, MAPK14, SOD2, RPS6KB1, TEK]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[IL1RN, IFITM1, SERPINE1, ADARB1, CXCL13, DACH1, ARHGDIB, DPYSL3, CYP1B1, HOXA7, MEF2C, IGFBP5, CD300A, IGFBP3, TPM1, MIF, SFRP2, PADI2, TRIB1, NBL1, VCL, TACSTD2, THY1, KLRK1, RRAS, STAP1, HMOX1, TGFB1, JAG1, JUP, NR2F2, CXCL12, BCL2, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, GREM1, TMEFF2, PLCB1, ENG, CX3CR1, SP100, LRP1, THBS1, AIF1, CCL2, IL33, CCL21, TIE1, PODN, KLF4, SULF1, COL3A1, DLC1]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[SPARC, SERPINE1, MYLK, ICAM1, LGALS3, C3AR1, AKT1, IL1R1, PRKCE, ACTN4, IL23A, PFN1, KIF20B, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, FN1, PPBP, IGF1, PTK2, COL1A1, NOX4, SNAI2, NRP1, NRP2, CD40, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, ANXA1, ANXA3, GAB1, SIRT1, F3, IL1A, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, AIF1, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CD74, CCL21, CCL20, F2RL1, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, ETS1, SLC8A1, CXCL16, PYCARD, PLAU, IL6R, PDGFRB, PDGFRA, POSTN, SEMA6A, IGFBP5, F2R, ADAM9, ADAM8, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, SELP, VIL1, CXCL10, CXCL11, IL6, BMP2, DAB2, CXCL12, PTPRC, NR4A3, BCL2, DOCK5, CXCL6, CXCL9, DOCK4, TNFAIP6, ITGB3, PIK3CD, LAMC2, CXCL1, CXCL3, PIK3C2A, CXCL2, CXCL5, CYR61, ITGA4, MMP9, FGR, IFNG, XCL2, XCL1, LEF1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, SEMA4A, EGF, SEMA4B, LAMB1, MAPK14, SOD2, RPS6KB1, TEK]
GO:0061551;trigeminal ganglion development;6.0;1.0;0.8231203125901445;9.628524252492122;32.51846529594618;8.390779266560578;0.0010883637687365787;0.7522251544931926;[NRP1]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CYFIP1, PLXND1, LST1, ICAM1, EPS8, TPM1, VRK1, CSF1R, EPB42, ARHGAP15, CORO1A, SPTA1, EPB41L3, MYH14, MYH10, FN1, CDC7, PARVB, PTK2, VIL1, FES, PLXNB2, ITGB2, ANXA1, RHOG, ARAP3, RHOH, ARAP1, RHOC, FGR, HCK, KIT, ITGA7, RHOU, CCL13, FGD3, FGD4, CCL7, PDPN, CCL2, FYN, WASF3, SEMA4A, DLC1]
GO:2000060;positive regulation of ubiquitin-dependent protein catabolic process;10.0;0.811012628672052;0.8207473261969463;9.483342242647623;1661.590298646008;5.192106149009898;0.055611931961498426;0.6807655617789147;[LRRK2, CLU, AKT1, CBFA2T3, RNF144A, RNF144B, TRIB1, CEBPA, AURKA, IL33, EGF, PLK2, CAV1, PLK1, PTK2, DAB2, CCDC22]
GO:0060982;coronary artery morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;32.54494596988572;7.57984905034425;0.0010892500530622757;0.710754145523778;[NRP1, LRP2]
GO:1901166;neural crest cell migration involved in autonomic nervous system development;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;23.960267269578353;8.390779266560578;8.01928582672223E-4;0.7800242071602487;[NRP1]
GO:0051591;response to cAMP;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;79.54904468548885;5.192106149009898;0.0026624349361310785;0.5886448625081389;[SPARC, PTAFR, AQP9, SLC8A1, AQP1, THBD, JUNB, JUN, IGFBP5, DUSP1, STAT1, FOS, NME1, COL1A1, FOSL1, KCNQ1, NDUFS4, NOX4, SDC1, MMP19, FOSB, TEK, SLC26A3, CFTR, BIRC2]
GO:1902378;VEGF-activated neuropilin signaling pathway involved in axon guidance;10.0;1.0;0.9152410118609203;9.628524252492122;58.60337150540505;9.777073627680469;0.0019614021046756975;0.9152410118609203;[NRP1]
GO:1903225;negative regulation of endodermal cell differentiation;8.0;0.9326813400603323;0.8413406700301662;9.577230958104572;302.8138100707639;8.67846133901236;0.010134905708332559;0.8188169164668168;[COL5A1, COL5A2]
GO:0060627;regulation of vesicle-mediated transport;5.0;0.4849414530207067;0.5327117383712736;6.805163204878917;26.124861613659725;3.5745381104925467;8.743756073601922E-4;0.47304305706453076;[SERPINE1, LGALS3, SLC11A1, ACTN4, SFRP4, ZFYVE16, EPHA3, CFTR, LLGL2, STXBP2, NEDD4L, C2, C3, PLCG2, HMOX1, NCKAP1L, CD14, LYN, AZU1, TF, SDC1, NRP1, RAC2, CD36, CCR2, ANXA1, FCER1G, SYK, GAB2, RAB33B, HCK, CEACAM1, IL1B, GAS1, TLR2, NAPA, PTAFR, GNAI2, NTF3, CCL19, CCL21, NR1H2, LILRB1, SNX17, F2RL1, GOPC, FMR1, SIRPG, TNF, CLU, PYCARD, SIRPA, IL13RA2, CD177, MAP2K2, CD300A, TSC2, HGS, PRTN3, CD151, CORO1A, TMEM27, STAP1, CD300LF, EVI5, TGFB1, SYT2, CAV1, SELE, TBCK, DAB2, SYNJ1, FES, MCTP1, ITGAM, LRRK2, ITGB2, ARRB1, ARRB2, SIRPB1, TBC1D8, TBC1D9, DNM2, FGR, GREM1, IFNG, DOCK2, NLGN1, LRP1, VPS4B, DLL1, RAB21, CCL2, CSK, SNCA, EGF, VPS41, PTX3, FCGR2B]
GO:0001570;vasculogenesis;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;21.066225782797595;5.6339389012889365;7.050676185779127E-4;0.5381198974168686;[YAP1, ADM, GJC1, TMEM100, HHEX, JUNB, MYOCD, TGFB1, CAV1, TIE1, PTK2, TGFBR3, ENG]
GO:1904835;dorsal root ganglion morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;28.42528359967652;9.777073627680469;9.513686609867987E-4;0.7902410118609202;[NRP1]
GO:0010718;positive regulation of epithelial to mesenchymal transition;6.0;0.811012628672052;0.7286266269261705;9.377209824211215;170.70262580884207;5.9928839937622085;0.005713263263432726;0.6295966787287501;[HDAC2, TGFB1I1, LEF1, TWIST1, LOXL2, EPB41L5, PDPN, TGFB2, TGFB1, AXIN2, COL1A1, BMP2, DAB2, IL1B, EZH2, ENG]
GO:0071230;cellular response to amino acid stimulus;6.0;0.7140352122741334;0.6801379187272112;8.962045319014338;283.89643900763554;5.6339389012889365;0.009501758323378283;0.6112402100070131;[CEBPB, DNMT1, ABCB4, UBR1, TNF, SESN3, PDGFD, PDGFC, FYN, PDGFRA, MMP2, CYBB, COL1A1, COL3A1, COL1A2, ZEB1, COL4A1, COL5A2, COL6A1, RRAGD, BCL2L1]
GO:0050771;negative regulation of axonogenesis;10.0;0.7436939687323844;0.7870879962271125;9.36383169826504;885.0968544383536;5.54296712308321;0.029623395182598163;0.6987086083097278;[NRP1, SEMA5B, RNF6, THY1, ARHGAP4, ARHGDIA, SPP1, TNR, EPHB2, LINGO1, SEMA4A, SEMA6A, DCC, SEMA4B, PTK2]
GO:0001569;branching involved in blood vessel morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.375876246018314;0.0017907488225476112;0.6769819729871445;[NRP1, EDN1, PLXND1, LEF1, IHH, EDNRA, SFRP2, COL4A1, ENG]
GO:0045112;integrin biosynthetic process;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;39.16312370347755;9.777073627680469;0.0013107545058323288;0.7902410118609202;[COL5A1]
GO:0043297;apical junction assembly;6.0;1.0;0.8231203125901445;9.628524252492122;56.140948375987016;7.697632086000634;0.001878987018571015;0.7167775754447168;[CTNNA1, RHOC, VCL]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, ZFAND6, RORA, BRCA1, ICAM1, PYCARD, TCL1A, AKT1, EDN1, POSTN, CHUK, SIRT1, XCL2, CHI3L1, XCL1, CCL13, CEBPA, CALCA, GATA3, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, VCAM1, CCL21, CCL20, MAPK14, NFKB1, COL1A1]
GO:0014911;positive regulation of smooth muscle cell migration;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;201.77833622021802;6.280566066213989;0.0067533393245778365;0.6961884407023742;[PDGFRB, DOCK5, NRP1, DOCK4, POSTN, IGFBP5, IGF1, AIF1, P2RY6, PAK1, NR4A3, RPS6KB1, CCL5, PDGFD, BCL2, NOX4]
GO:0032464;positive regulation of protein homooligomerization;8.0;0.9326813400603323;0.8413406700301662;9.56398573135455;175.26005477141007;7.57984905034425;0.005865796309390097;0.7626338329336335;[BIK, RHOC, CLU]
GO:0060193;positive regulation of lipase activity;6.0;0.7671156992804218;0.7066781622303554;9.186691500213083;50.03060230748208;5.587418885654044;0.001674479234612594;0.6088611742440427;[ITK, TXK, C5AR1, PTAFR, PRKCZ, RASGRP4, CYR61, EDNRA, GNA15, CCL5, PLCG1, PDGFRB, PDGFRA, NR1H2, AVPR1A, RHOC, SELE, GNAQ, KIT, AGTR1]
GO:0031532;actin cytoskeleton reorganization;6.0;1.0;0.8231203125901445;9.628524252492122;32.01253927882412;5.788089581116195;0.001071430880247358;0.6191234829421188;[NRP1, PLEK, ANTXR1, PRKCZ, PAK1, FLNA, CXADR, ANXA1, GAB1, PARVB, KIT, S100A9]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[, CYFIP1, TFRC, CLEC10A, SLA2, MYB, TRBC1, C3AR1, UBASH3A, PGLYRP1, PRKACB, MED1, MEF2C, CXADR, PRKCH, PRKCB, PRKCE, PRKCD, SERPING1, PRKCQ, CFB, CFD, CFH, HHLA2, PRKDC, CFI, FPR1, FPR3, FPR2, GATA3, THY1, CFP, PRKCZ, SAMSN1, C2, C3, KLRK1, C7, PLCG2, HMOX1, NCKAP1L, S100A14, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, ELANE, LYN, JUN, HLA-DRB4, FZD5, KIR2DS1, KIR2DS2, COL1A1, COL1A2, HLA-DRB1, DENND1B, ITK, SIGLEC9, IFIH1, CTLA4, JAK3, HLA-DPA1, HAVCR2, ANXA1, DUSP3, ARG1, IFNGR1, RIPK2, FCRL3, NFAM1, IFNGR2, PAWR, SERPINB9, PAX5, FOS, SIRT1, MMP12, FCER2, PLSCR1, RARA, TLR10, HLA-DQB1, PTAFR, UNG, NRAS, HLA-DMB, CCL19, IL12RB1, STAT1, NR1H2, CARD9, NR1H4, KIR3DL1, COL3A1, HLA-DPB1, PKN1, CLC, SIGLEC7, LGR4, PROS1, CXCL13, TNF, CLU, PYCARD, IGHG1, FCGRT, GRAP2, IL13RA2, CD177, LAG3, CD180, MSH6, CLEC4A, ADCYAP1, CLEC4D, MSH2, ADAM8, CLEC4E, S100A9, S100A8, BLK, CD274, LY96, CLEC7A, IGLV1-44, CD300LF, MAP2K6, EIF2B3, BMX, NFKB1, PTPRC, BCL6, BCL2, HLA-DRA, LAT, MYD88, ITGAM, ITGB2, PIK3CD, TREM2, PTPN22, ARRB2, ITGAL, TREM1, TNFSF13B, FCGR3A, DUSP10, ITGB7, CR2, CR1, GPX1, CHUK, ITGA4, PVRIG, LCK, XCL1, LCP2, PIK3C3, BIRC2, BIRC3, C1S, UNC93B1, C1R, NLRC3, NLRC4, NOD2, CCL5, FYN, CSK, FCGR1A, FCGR1B, FCGR2A, IL2RA, PTPN6, MNDA, CD247, FCGR2B, CLEC2D, IFITM1, GFI1, ICAM2, ICAM3, ICAM1, LGALS3, DHX58, ICOSLG, RSAD2, SLC11A1, HLA-B, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IL23A, BTK, TXK, STXBP2, CD1E, CD1D, CD1C, CD1B, CD1A, CD79B, CD79A, CD19, INPP5D, SLAMF7, CD14, A2M, PAG1, SH2D1A, TNFSF13, PILRA, PTK2, MARCO, CD28, CD24, CD200, IGHM, ECM1, CD40, IFNA2, CD3G, CD3E, CD3D, CTSS, RAC2, FCER1A, CTSH, MUC13, CD38, FFAR2, CTSG, CCR7, MUC15, CD36, CD34, CD33, CCR2, IL10, FCER1G, SYK, IL15, IL18, GAB2, PARP9, LIME1, VAV1, LAT2, TLR1, NCR1, HCK, CEACAM1, IL1B, KIT, IGHD, TLR8, TLR7, CD48, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA1, LILRA2, RELB, PAK1, IGKC, NPDC1, CD74, IL33, LILRB1, LILRB2, MLH1, LILRB4, CD40LG, F2RL1, C1QC, CD86, FCN1, CD80, TRAC, IL18RAP, IL6R, CD96, CD300A, THEMIS, MUC3B, OSCAR, TYROBP, CD8B, CD8A, KLRF1, CD300C, CARD11, KLRB1, C5AR1, KIR2DL1, KIR2DL2, CACNA1F, DDX60, KIR2DL3, RASGRP1, KIR2DL4, STAP1, NLRP3, LPXN, KLRC1, BTNL8, TGFB2, TGFB1, VCAM1, CAV1, CRTAM, NFKBIA, IL6, NR4A3, SELL, FES, KLRD1, IL7R, NFKBID, IGKV3-20, HMGB2, TNFAIP3, PDE4B, DDX58, MMP2, PDE4D, IRAK3, FGR, ZAP70, IFNG, LTA, IRF7, LTF, COLEC12, CLEC12B, SAMHD1, USP18, HSPD1, CNR1, HLX, TBX21, TRAT1, MAPK14, CD4, TNIP3]
GO:0061549;sympathetic ganglion development;5.0;1.0;0.7902410118609202;9.628524252492122;31.419853007278505;7.57984905034425;0.0010515942041217404;0.6778748447945537;[NRP1, NRP2]
GO:1902946;protein localization to early endosome;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;33.466755985853425;8.67846133901236;0.001120102204721561;0.7947362817240173;[NRP1]
GO:0070372;regulation of ERK1 and ERK2 cascade;10.0;0.8653626801206646;0.8479223519212526;9.541512875502493;158.98679164778278;4.069963362931594;0.0053211448376282704;0.623379127513894;[PHB2, TNF, CTGF, ICAM1, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, ATF3, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FBLN1, FPR2, TNFRSF11A, SLC30A10, PRKCZ, RASGRP1, PKHD1, RRAS, PDGFD, PDGFC, FAM83D, SLAMF1, LYN, CCR1, JUN, TGFB1, LIF, FN1, MARCO, BMP2, NOX4, NRP1, PTPRR, TREM2, PTPN22, ARRB1, ARRB2, CYR61, DUSP10, TIMP3, CCR7, EMILIN1, CD36, HAVCR2, DUSP3, SYK, DUSP1, RIPK2, DUSP6, CEACAM1, IL1B, KIT, XCL2, CHI3L1, XCL1, TLR4, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CSK, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, KLF4, CD4, NLRP12, F2RL1, PTPN6, TEK]
GO:0035729;cellular response to hepatocyte growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;78.10713999468214;7.138016298065211;0.00261417568375975;0.6881587980249038;[IL10, VIL1, NRP1, MED1]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, ADARB1, SLA2, HERC5, LGALS3, TRBC1, DHX58, TRIM25, PGLYRP1, RNASE6, RNASE3, MIF, HLA-E, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, CFB, CFD, CFH, PRKDC, TXK, CFI, GATA3, CD1D, CFP, LY9, C2, C3, KLRK1, C7, SLAMF7, S100A12, CD14, IGHA1, SLAMF1, LYN, SIGLEC16, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, EIF2AK2, PTK2, MARCO, VNN1, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, JAK3, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, RIPK2, IL18, PARP9, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA2, LILRA5, RELB, IGKC, CARD9, NR1H4, KIR3DL1, F2RL1, LGR4, C1QC, FCN1, NCF1, NCF2, SLA, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, MATK, CYBB, CLEC4A, CLEC4D, TYROBP, CLEC4E, S100A9, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, NFKB2, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, PIK3CD, TREM2, TREM1, SIRPB1, PSTPIP1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, LCK, IRF7, LTF, COLEC12, C1S, UNC93B1, C1R, HIST1H2BK, NLRC4, NOD2, FYN, CSK, MX2, GZMB, PML, GZMM, CD6, PTX3, PTPN6, CD244]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, ICAM1, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FPR2, TNFRSF11A, SLC30A10, PRKCZ, RASGRP1, PDGFD, PDGFC, SLAMF1, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, ARRB1, ARRB2, CCR7, CD36, HAVCR2, RIPK2, IL1B, KIT, XCL2, CHI3L1, XCL1, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, CD4, F2RL1, TEK]
GO:0071345;cellular response to cytokine stimulus;5.0;0.6729672293956388;0.6267246265587396;8.214830917184116;61.59823360834823;3.805811787890007;0.0020616374440603005;0.48487040368196277;[PID1, TFRC, IFIT1, IFIT3, IFIT2, ICAM1, TCL1A, DPYSL3, AKT1, TNFSF11, TRIM25, DAPK1, CDC34, BTK, PADI2, STXBP2, GATA3, ADAMTS12, ST3GAL6, EGR1, COL1A1, CD40, BRCA1, CCR7, HLA-DPA1, EDN1, MME, ARG1, SIRT1, HCLS1, TLR4, TLR2, CCL13, SELPLG, CXCR4, AIF1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, STAT1, LAPTM5, POU4F1, NLRP12, ZYX, IL18R1, IL17A, CSF3, CSF2, ZFAND6, RORA, PYCARD, TLE4, POSTN, PCOLCE, KMO, KIF16B, CSF1R, CALCA, TCF7, CSF2RB, CORO1A, SBNO2, VCAM1, NFKB1, BSPRY, ALAD, MYBL2, CHUK, ITGA4, IL3RA, XCL2, CHI3L1, XCL1, IRF8, MCM2, CEBPA, CEBPB, LEF1, THBS1, CCL8, CCL7, CCL5, SPOCK2, CCL4, CCL2, CCL1, MAPK14, KLF4, PML, MAPK13, CD4, KLF5, RPS6KB1, IMPDH2, PTPN6, PTPN7, PTPN4, RBMX]
GO:0030950;establishment or maintenance of actin cytoskeleton polarity;6.0;1.0;0.8231203125901445;9.628524252492122;64.1120899346335;7.212124270218933;0.002145773952977257;0.6919486831672181;[RHOC, AQP1]
